Article thumbnail

The Human Gonadotropin Releasing Hormone Type I Receptor Is a Functional Intracellular GPCR Expressed on the Nuclear Membrane

By Michelle Re, Macarena Pampillo, Martin Savard, Céléna Dubuc, Craig A. McArdle, Robert P. Millar, P. Michael Conn, Fernand Gobeil, Moshmi Bhattacharya and Andy V. Babwah

Abstract

The mammalian type I gonadotropin releasing hormone receptor (GnRH-R) is a structurally unique G protein-coupled receptor (GPCR) that lacks cytoplasmic tail sequences and displays inefficient plasma membrane expression (PME). Compared to its murine counterparts, the primate type I receptor is inefficiently folded and retained in the endoplasmic reticulum (ER) leading to a further reduction in PME. The decrease in PME and concomitant increase in intracellular localization of the mammalian GnRH-RI led us to characterize the spatial distribution of the human and mouse GnRH receptors in two human cell lines, HEK 293 and HTR-8/SVneo. In both human cell lines we found the receptors were expressed in the cytoplasm and were associated with the ER and nuclear membrane. A molecular analysis of the receptor protein sequence led us to identify a putative monopartite nuclear localization sequence (NLS) in the first intracellular loop of GnRH-RI. Surprisingly, however, neither the deletion of the NLS nor the addition of the Xenopus GnRH-R cytoplasmic tail sequences to the human receptor altered its spatial distribution. Finally, we demonstrate that GnRH treatment of nuclei isolated from HEK 293 cells expressing exogenous GnRH-RI triggers a significant increase in the acetylation and phosphorylation of histone H3, thereby revealing that the nuclear-localized receptor is functional. Based on our findings, we conclude that the mammalian GnRH-RI is an intracellular GPCR that is expressed on the nuclear membrane. This major and novel discovery causes us to reassess the signaling potential of this physiologically and clinically important receptor

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2900216
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2000). A functional angiotensin II receptor-GFP fusion protein: evidence for agonistdependent nuclear translocation.
  2. (2001). A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression.
  3. (2003). Activation of metabotropic glutamate receptor mGlu5 on nuclear membranes mediates intranuclear Ca2+ changes in heterologous cell types and neurons.
  4. (2005). Addition of a signal peptide sequence to the alpha1D-adrenoceptor gene increases the density of receptors, as determined by [3H]-prazosin binding in the membranes.
  5. (2004). Agonistindependent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors.
  6. (2006). AKAP79-mediated targeting of the cyclic AMP-dependent protein kinase to the beta1-adrenergic receptor promotes recycling and functional resensitization of the receptor.
  7. (1998). Angiotensin II-induced nuclear targeting of the angiotensin type 1 (AT1) receptor in brain neurons.
  8. (1987). Binding and internalization of native gonadoliberin (GnRH) by anterior pituitary gonadotrophs of the rat. A quantitative autoradiographic study after cryoultramicrotomy.
  9. (2006). Calnexin regulated gonadotropinreleasing hormone receptor plasma membrane expression.
  10. (1994). Chromosomal localization of the gonadotropin-releasing hormone receptor gene to human chromosome 4q13.1-q21.1 and mouse chromosome 5.
  11. (1992). Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor.
  12. (2000). Combined modification of intracellular and extracellular loci on human gonadotropin-releasing hormone receptor provides a mechanism for enhanced expression.
  13. (1995). Effects of second intracellular loop mutations on signal transduction and internalization of the gonadotropin-releasing hormone receptor.
  14. (1993). Establishment and characterization of first trimester human trophoblast cells with extended lifespan.
  15. (2003). Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression.
  16. (2008). Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activation.
  17. (2003). Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes.
  18. (2005). Functional metabotropic glutamate receptors on nuclei from brain and primary cultured striatal neurons. Role of transporters in delivering ligand.
  19. (2006). G-Protein Coupled Receptors Signalling at the Cell Nucleus: An emerging paradigm.
  20. (2002). Gonadotropin releasing hormone receptor expression in primary breast cancer: comparison of immunohistochemical, radioligand and Western blot analyses.
  21. (2004). Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphaicoupling state of the type I GnRH receptor.
  22. (2000). Gonadotropin-releasing hormone receptor initiates multiple signaling pathways by exclusively coupling to G(q/11) proteins.
  23. (2009). Gonadotropin-releasing hormone-regulated chemokine expression in human placentation.
  24. (2005). Heterodimerization with beta2-adrenergic receptors promotes surface expression and functional activity of alpha1D-adrenergic receptors.
  25. (2004). Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting.
  26. (2006). Identification of a gonadotropin-releasing hormone receptor orthologue in Caenorhabditis elegans.
  27. (2005). In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles.
  28. (2005). Inefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surface.
  29. (2005). Interaction with the unfolded protein response reveals a role for stargazin in biosynthetic AMPA receptor transport.
  30. (2005). Internalization of gonadotropin-releasing hormone receptors (GnRHRs): does arrestin binding to the C-terminal tail target GnRHRs for dynamin-dependent internalization?
  31. (2006). Intracellular gonadotropin-releasing hormone receptors in breast cancer and gonadotrope lineage cells.
  32. (2002). Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation.
  33. (1983). Luteinizing hormone-releasing hormone (LH-RH) binding to purified rat pituitary nuclei.
  34. (2001). Maya-Nu ´n ˜ez G, Conn PM
  35. (2008). Multiple G proteins compete for binding with the human gonadotropin releasing hormone receptor.
  36. (2007). NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling.
  37. (1993). Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA.
  38. (1999). nuclear envelope.
  39. (2007). Nuclear localization of functional metabotropic glutamate receptor mGlu1 in HEK293 cells and cortical neurons: role in nuclear calcium mobilization and development.
  40. (1998). Nuclear localization of prostaglandin E2 receptors.
  41. (2000). Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation.
  42. (2000). Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues.
  43. (2008). Plasma membrane expression of GnRH receptors: regulation by antagonists in breast, prostate, and gonadotrope cell lines.
  44. (2003). Protein kinase C isoform-specific differences in the spatial-temporal regulation and decoding of metabotropic glutamate receptor1a-stimulated second messenger responses.
  45. (2004). Ral and phospholipase D2-dependent pathway for constitutive metabotropic glutamate receptor endocytosis.
  46. (2002). Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism.
  47. (2007). Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.
  48. (2002). Regulation of eNOS Expression
  49. (2006). Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy.
  50. (2000). Regulation of human gonadotropin-releasing hormone receptor gene expression in placental cells.
  51. (2004). RTP family members induce functional expression of mammalian odorant receptors.
  52. (1989). Sequence requirements for synthetic peptide-mediated translocation to the nucleus.
  53. (2003). Structureactivity relations of successful pharmacologic chaperones for rescue of naturally GnRH-RI,
  54. (1998). Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy.
  55. (2004). The basic residues in the membrane-proximal C-terminal tail of the rat melanin-concentrating hormone receptor 1 are required for receptor function.
  56. (2005). The composition of the beta-2 adrenergic receptor oligomer affects its membrane trafficking after ligandinduced endocytosis.
  57. (1994). The concentration of LH-RH receptors in the nuclei of pancreatic cancer cells. Effect of (D-Trp6)LH-RH on tumor-bearing Syrian golden hamsters.
  58. (2003). Unexpected effects of epitope and chimeric tags on gonadotropin-releasing hormone receptors: implications for understanding the molecular etiology of hypogonadotropic hypogonadism.